Mouse models bearing knock-in mutations of p53 showed that mutant p53 proteins can drive tumor formation, invasion and metastasis through dominant negative inhibition of wild-type p53 along with gain-of-function or ‘neomorphic’ activities that can inhibit or activate the function of other proteins [34], [35]. Here, TP53 is linked to neoplasm.